Covexin 10

Clostridium perfringens anatoxina tip A, Clostridium perfringens anatoxina tip B şi C, Clostridium perfringens anatoxina tip D, Cultură de Clostridium chauvoei, Anatoxină de Clostridium novyi, Anatoxină de Clostridium septicum, Anatoxină de Clostridium tetani, Anatoxină de Clostridium sordellii, Anatoxină de Clostridium haemolyticum

Product information

Trade name: Covexin 10

Active substance: Clostridium perfringens anatoxina tip A, Clostridium perfringens anatoxina tip B şi C, Clostridium perfringens anatoxina tip D, Cultură de Clostridium chauvoei, Anatoxină de Clostridium novyi, Anatoxină de Clostridium septicum, Anatoxină de Clostridium tetani, Anatoxină de Clostridium sordellii, Anatoxină de Clostridium haemolyticum

Therapeutic group: Organic products

Pharmaceutical form: suspensie injectabilă

Presentation: flacon x 50, 100 ml.

Target species: cattle, sheep

Therapeutic action: Ovine şi bovine Imunizarea activă împotriva bolilor asociate cu infecţii cauzate de Clostridium perfringens tip A, C, perfringens tip B, C, perfringens tip C,C, perfringens tip D, Clostridium chauvoei, Clostridium novyi tip B, Clostridium septicum, Clostridium sordellii şi Clostridium haemolyticum şi împotriva tetanusului cauzat de Clostridium tetani.

Waiting period: 0 zile.

Release mode: Cu prescripţie

Authorization data

Authorization number: 150422

Authorization status: Valida

Date of issue of the authorization: 09-10-2015

Authorization valid until: nelimitata

Manufacturer / Serial Release Company: ZOETIS BELGIUM SA, Belgia

Licensee: ZOETIS BELGIUM SA, Belgia

Responsible company in Romania: ZOETIS ROMANIA SRL

Remarks: Autorizat prin MRP.